Metraipolis › archive › dc_be61713f9d2e
Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42682597
- DOI
- 10.3389/fphar.2026.1895503
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:45:50.362Z
- SHA-256 of the archived text
adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd- Stable URL of this page
https://metraipolis.com/documento/dc_be61713f9d2e
How to cite
Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597 — Europe PMC (en), https://europepmc.org/article/MED/42682597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be61713f9d2e (Metraipolis archive dc_be61713f9d2e, sha256 adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd)
BibTeX
@misc{dcbe61713f9d2e,
title = {Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42682597},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be61713f9d2e; sha256 adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42682597. Agents can read the archived copy with the MCP tool read_document.